SMAD2 and metabolic dysfunction-associated steatotic liver disease: Our results revealed that exosomes derived from rats with OSA promoted hepatic steatosis to increase the severity of liver damage in MASLD, and the possible molecular mechanism is the increased activity of the TCONS_00039830/miR-455-3p/Smad2 axis.